A new immunotherapy target? How SRC-3 in Tregs may reshape solid-tumor treatment

by Ana María Rodríguez,Baylor College of MedicineThe loss of SRC-3 in Treg leads to immune suppression of glioblastoma in mice: (A) Experimental design for the orthotopic injection of glioblastoma cel

Updated on: May 23,2026

A new immunotherapy target? How SRC-3 in Tregs may reshape solid-tumor treatment

by Ana María Rodríguez,Baylor College of MedicineThe loss of SRC-3 in Treg leads to immune suppression of glioblastoma in mice: (A) Experimental design for the orthotopic injection of glioblastoma cel

Updated on:May 23,2026

Why some cancer therapies don't work for all patients: A tumor backup survival pathway

by Anne Trafton,Massachusetts Institute of TechnologyMany of the targeted tumors turn on a backup survival pathway that helps them keep growing when tyrosine kinase—pictured here as strands—is turned

Updated on: May 26,2026

Why some cancer therapies don't work for all patients: A tumor backup survival pathway

by Anne Trafton,Massachusetts Institute of TechnologyMany of the targeted tumors turn on a backup survival pathway that helps them keep growing when tyrosine kinase—pictured here as strands—is turned

Updated on:May 26,2026

Cause or effect? Study answers question about gene linked with colorectal cancer

by Jacqueline Mitchell,Harvard Medical SchoolIn mice lacking the COSMC gene, gut cells underwent vast changes in appearance and gene activity that predisposed them to develop into colorectal cancer. H

Updated on: June 08,2026

Cause or effect? Study answers question about gene linked with colorectal cancer

by Jacqueline Mitchell,Harvard Medical SchoolIn mice lacking the COSMC gene, gut cells underwent vast changes in appearance and gene activity that predisposed them to develop into colorectal cancer. H

Updated on:June 08,2026

uPAR-targeted CAR T cells shrank solid tumors and cleared metastases in mice

byMemorial Sloan Kettering Cancer CenterCredit:Cell(2026). DOI: 10.1016/j.cell.2026.03.002Chimeric antigen receptor T-cell therapy—CAR T for short—has been a major advance in treating blood cancers li

Updated on: May 20,2026

uPAR-targeted CAR T cells shrank solid tumors and cleared metastases in mice

byMemorial Sloan Kettering Cancer CenterCredit:Cell(2026). DOI: 10.1016/j.cell.2026.03.002Chimeric antigen receptor T-cell therapy—CAR T for short—has been a major advance in treating blood cancers li

Updated on:May 20,2026

Genetic variants involved in rapid immune response linked to earlier breast cancer onset in BRCA1 carriers

byBritish Medical JournalCredit: CC0 Public DomainDamaging variants in genes involved in a rapid immune response (innate immunity) are significantly linked to earlier breast cancer onset in carriers o

Updated on: May 24,2026

Genetic variants involved in rapid immune response linked to earlier breast cancer onset in BRCA1 carriers

byBritish Medical JournalCredit: CC0 Public DomainDamaging variants in genes involved in a rapid immune response (innate immunity) are significantly linked to earlier breast cancer onset in carriers o

Updated on:May 24,2026

AI learns to make sense of childhood cancer survivors' health care needs

bySt. Jude Children's Research HospitalCredit: SHVETS production from PexelsArtificial intelligence (AI) could help physicians determine if survivors of childhood cancer need extra support—and the

Updated on: May 28,2026

AI learns to make sense of childhood cancer survivors' health care needs

bySt. Jude Children's Research HospitalCredit: SHVETS production from PexelsArtificial intelligence (AI) could help physicians determine if survivors of childhood cancer need extra support—and the

Updated on:May 28,2026

Rearranging tumor cell structures—new approach could treat cancer

by Tim Tedeschi,University of CincinnatiBiomedical research typically follows a familiar path: developing treatments that block, enhance or mutate certain signaling pathways, genes or proteins to chan

Updated on: March 28,2026

Rearranging tumor cell structures—new approach could treat cancer

by Tim Tedeschi,University of CincinnatiBiomedical research typically follows a familiar path: developing treatments that block, enhance or mutate certain signaling pathways, genes or proteins to chan

Updated on:March 28,2026

Early results from a trial of active surveillance for low-risk ductal carcinoma in situ are 'reassuring'

by European Organisation for Research and Treatment of CancerCredit: Unsplash/CC0 Public DomainResearchers leading a trial of active surveillance for ductal carcinoma in situ (DCIS) have described ear

Updated on: May 30,2026

Early results from a trial of active surveillance for low-risk ductal carcinoma in situ are 'reassuring'

by European Organisation for Research and Treatment of CancerCredit: Unsplash/CC0 Public DomainResearchers leading a trial of active surveillance for ductal carcinoma in situ (DCIS) have described ear

Updated on:May 30,2026

Supportive cancer care: Most patients say human touch outshines tech

by National Comprehensive Cancer NetworkCredit: Pixabay/CC0 Public DomainNew researchpublishedin the November 2025 issue ofJNCCN—Journal of the National Comprehensive Cancer Networkexplores the percep

Updated on: April 02,2026

Supportive cancer care: Most patients say human touch outshines tech

by National Comprehensive Cancer NetworkCredit: Pixabay/CC0 Public DomainNew researchpublishedin the November 2025 issue ofJNCCN—Journal of the National Comprehensive Cancer Networkexplores the percep

Updated on:April 02,2026

FDA warns biotech firm over cancer drug claims

by HealthDay StaffThe U.S. Food and Drug Administration (FDA) has warned a biotech company about claims that its bladder cancer drug could treat and prevent multiple types of cancer.The agency sent a

Updated on: April 22,2026

FDA warns biotech firm over cancer drug claims

by HealthDay StaffThe U.S. Food and Drug Administration (FDA) has warned a biotech company about claims that its bladder cancer drug could treat and prevent multiple types of cancer.The agency sent a

Updated on:April 22,2026

Study shows supervised exercise improves strength, physical performance in patients with advanced breast cancer

by Associação Advanced Breast Cancer Global AllianceWhole body lean mass, which is an indicator of muscle mass, increased in the exercise group, while it decreased in the control group. Credit: Anne M

Updated on: April 01,2026

Study shows supervised exercise improves strength, physical performance in patients with advanced breast cancer

by Associação Advanced Breast Cancer Global AllianceWhole body lean mass, which is an indicator of muscle mass, increased in the exercise group, while it decreased in the control group. Credit: Anne M

Updated on:April 01,2026

RNA-based molecule enhances therapies against pancreatic cancer

byItalian Institute of TechnologyThe small ring-like structures visible in the magnified area represent the RAD51 protein, which has adopted a non-functional shape as a result of its interaction with

Updated on: March 27,2026

RNA-based molecule enhances therapies against pancreatic cancer

byItalian Institute of TechnologyThe small ring-like structures visible in the magnified area represent the RAD51 protein, which has adopted a non-functional shape as a result of its interaction with

Updated on:March 27,2026